vs

Side-by-side financial comparison of DuPont (DD) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

DuPont is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.7× Everus Construction Group, Inc.). DuPont runs the higher net margin — 9.8% vs 5.5%, a 4.3% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 4.0%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -27.2%).

DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.

DD vs ECG — Head-to-Head

Bigger by revenue
DD
DD
1.7× larger
DD
$1.7B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+29.2% gap
ECG
33.2%
4.0%
DD
Higher net margin
DD
DD
4.3% more per $
DD
9.8%
5.5%
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-27.2%
DD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DD
DD
ECG
ECG
Revenue
$1.7B
$1.0B
Net Profit
$164.0M
$55.3M
Gross Margin
35.8%
11.6%
Operating Margin
6.8%
Net Margin
9.8%
5.5%
Revenue YoY
4.0%
33.2%
Net Profit YoY
60.4%
EPS (diluted)
$0.36
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DD
DD
ECG
ECG
Q1 26
$1.7B
Q4 25
$-2.5B
$1.0B
Q3 25
$3.1B
$986.8M
Q2 25
$3.3B
$921.5M
Q1 25
$3.1B
$826.6M
Q4 24
$3.1B
$759.6M
Q3 24
$3.2B
$761.0M
Q2 24
$3.2B
$703.4M
Net Profit
DD
DD
ECG
ECG
Q1 26
$164.0M
Q4 25
$-126.0M
$55.3M
Q3 25
$-123.0M
$57.0M
Q2 25
$59.0M
$52.8M
Q1 25
$-589.0M
$36.7M
Q4 24
$-118.0M
$34.5M
Q3 24
$454.0M
$41.8M
Q2 24
$178.0M
$39.0M
Gross Margin
DD
DD
ECG
ECG
Q1 26
35.8%
Q4 25
11.6%
Q3 25
38.9%
12.6%
Q2 25
37.3%
13.0%
Q1 25
37.4%
11.2%
Q4 24
36.4%
11.4%
Q3 24
37.4%
11.8%
Q2 24
37.1%
12.6%
Operating Margin
DD
DD
ECG
ECG
Q1 26
Q4 25
6.8%
Q3 25
10.6%
7.3%
Q2 25
9.4%
7.9%
Q1 25
-14.0%
6.2%
Q4 24
1.4%
6.1%
Q3 24
18.4%
7.1%
Q2 24
9.3%
7.3%
Net Margin
DD
DD
ECG
ECG
Q1 26
9.8%
Q4 25
4.9%
5.5%
Q3 25
-4.0%
5.8%
Q2 25
1.8%
5.7%
Q1 25
-19.2%
4.4%
Q4 24
-3.8%
4.5%
Q3 24
14.2%
5.5%
Q2 24
5.6%
5.5%
EPS (diluted)
DD
DD
ECG
ECG
Q1 26
$0.36
Q4 25
$-0.30
$1.09
Q3 25
$-0.29
$1.11
Q2 25
$0.14
$1.03
Q1 25
$-1.41
$0.72
Q4 24
$-0.28
$0.68
Q3 24
$1.08
$0.82
Q2 24
$0.42
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DD
DD
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$710.0M
Total DebtLower is stronger
$3.2B
$281.5M
Stockholders' EquityBook value
$14.2B
$629.8M
Total Assets
$21.4B
$1.7B
Debt / EquityLower = less leverage
0.22×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DD
DD
ECG
ECG
Q1 26
$710.0M
Q4 25
$715.0M
Q3 25
$2.0B
Q2 25
$1.8B
Q1 25
$1.8B
Q4 24
$1.9B
Q3 24
$1.6B
$553.0K
Q2 24
$1.5B
Total Debt
DD
DD
ECG
ECG
Q1 26
$3.2B
Q4 25
$3.1B
$281.5M
Q3 25
$7.0B
$285.1M
Q2 25
$5.3B
$288.6M
Q1 25
$5.3B
$292.1M
Q4 24
$5.3B
$295.6M
Q3 24
$7.2B
Q2 24
$7.2B
Stockholders' Equity
DD
DD
ECG
ECG
Q1 26
$14.2B
Q4 25
$13.9B
$629.8M
Q3 25
$22.9B
$573.0M
Q2 25
$23.1B
$514.4M
Q1 25
$22.8B
$460.2M
Q4 24
$23.4B
$422.6M
Q3 24
$24.2B
$453.3M
Q2 24
$23.3B
$490.0M
Total Assets
DD
DD
ECG
ECG
Q1 26
$21.4B
Q4 25
$21.6B
$1.7B
Q3 25
$38.0B
$1.6B
Q2 25
$36.6B
$1.5B
Q1 25
$36.0B
$1.4B
Q4 24
$36.6B
$1.3B
Q3 24
$37.5B
$1.3B
Q2 24
$36.6B
Debt / Equity
DD
DD
ECG
ECG
Q1 26
0.22×
Q4 25
0.23×
0.45×
Q3 25
0.31×
0.50×
Q2 25
0.23×
0.56×
Q1 25
0.23×
0.63×
Q4 24
0.23×
0.70×
Q3 24
0.30×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DD
DD
ECG
ECG
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
6.1%
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DD
DD
ECG
ECG
Q1 26
Q4 25
$-700.0M
$48.2M
Q3 25
$497.0M
$76.2M
Q2 25
$381.0M
$25.3M
Q1 25
$382.0M
$7.1M
Q4 24
$564.0M
Q3 24
$737.0M
$78.9M
Q2 24
$527.0M
Free Cash Flow
DD
DD
ECG
ECG
Q1 26
Q4 25
$-850.0M
$23.5M
Q3 25
$379.0M
$65.7M
Q2 25
$265.0M
$12.3M
Q1 25
$133.0M
$-11.4M
Q4 24
$403.0M
Q3 24
$628.0M
$60.9M
Q2 24
$425.0M
FCF Margin
DD
DD
ECG
ECG
Q1 26
Q4 25
33.4%
2.3%
Q3 25
12.3%
6.7%
Q2 25
8.1%
1.3%
Q1 25
4.3%
-1.4%
Q4 24
13.0%
Q3 24
19.7%
8.0%
Q2 24
13.4%
Capex Intensity
DD
DD
ECG
ECG
Q1 26
6.1%
Q4 25
-5.9%
2.4%
Q3 25
3.8%
1.1%
Q2 25
3.6%
1.4%
Q1 25
8.1%
2.2%
Q4 24
5.2%
Q3 24
3.4%
2.4%
Q2 24
3.2%
Cash Conversion
DD
DD
ECG
ECG
Q1 26
Q4 25
0.87×
Q3 25
1.34×
Q2 25
6.46×
0.48×
Q1 25
0.19×
Q4 24
Q3 24
1.62×
1.89×
Q2 24
2.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DD
DD

Segment breakdown not available.

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons